Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry

Journal of Rheumatology

Volumn 40, Issue 12, 2013, Pages 2088-2096

  Angeles Han, Sheila T ^a   Pelajo, Christina F ^b   Vogler, Larry B ^c   Rouster Stevens, Kelly ^d   Kennedy, Christine ^e   Ponder, Lori ^e   McCracken, Courtney ^a   Lopez Benitez, Jorge ^b   Drews Botsch, Carolyn ^f   Prahalad, Sampath ^a  

^a EMORY UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c Department of Pediatrics ^*  (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^f Depatment of Epidemiology   (United States)

Author keywords

Juvenile idiopathic arthritis; Outcomes; Risk markers; Uveitis

Indexed keywords

ANTINUCLEAR ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE REGISTRY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; UVEITIS;

JUVENILE IDIOPATHIC ARTHRITIS; OUTCOMES; RISK MARKERS; UVEITIS;

ADOLESCENT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGE OF ONSET; ARTHRITIS, JUVENILE; CHILD; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; PREVALENCE; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; SEX DISTRIBUTION; UNITED STATES; UVEITIS;

EID: 84889026455     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130302     Document Type: Article

References (44)

1. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
2. Cassidy JT, Petty RE, Laxer RM, Lindsley CB. Textbook of pediatric rheumatology. Philadelphia: Elsevier Saunders; 2005.
3. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol 2003;14:395-8.
4. Nordal EB, Songstad NT, Berntson L, Moen T, Straume B, Rygg M. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies. J Rheumatol 2009;36:1737-43.
5. Kanski JJ. Juvenile arthritis and uveitis. Surv Ophthalmol 1990;34:253-67.
6. Kesen MR, Setlur V, Goldstein DA. Juvenile idiopathic arthritis-related uveitis. Int Ophthalmol Clin 2008;48:21-38.
7. Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol 2003;48:489-502.
8. Zierhut M, Michels H, Stubiger N, Besch D, Deuter C, Heiligenhaus A. Uveitis in children. Int Ophthalmol Clin 2005;45:135-56.
9. Kanski JJ. Uveitis in juvenile chronic arthritis. Clin Exp Rheumatol 1990;8:499-503.
10. BenEzra D, Cohen E, Behar-Cohen F. Uveitis and juvenile idiopathic arthritis: a cohort study. Clin Ophthalmol 2007;1:513-8.
11. Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmol 2001;108:2071-5.
12. Sabri K, Saurenmann RK, Silverman ED, Levin AV. Course, complications, and outcome of juvenile arthritis-related uveitis. J AAPOS 2008;12:539-45.
13. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmol 1997;104:236-44.
14. Paroli MP, Speranza S, Marino M, Pirraglia MP, Pivetti-Pezzi P. Prognosis of juvenile rheumatoid arthritis-associated uveitis. Euro J Ophthalmol 2003;13:616-21.
15. Raymaekers A, Foets B, Wouters C, Casteels I. Visual outcome in children with juvenile idiopathic arthritis related uveitis. Bull Soc Belge Ophthalmol 2006;300:67-72.
16. Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 2007;46:1015-9.
17. Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss. Am J Ophthalmol 2007;143:840-6.
18. Angeles-Han ST, Yeh S, Vogler LB. Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis - A review. Int J Clin Rheumatol 2013;8:109-21.
19. Cassidy J, Kivlin J, Lindsley C, Nocton J. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 2006;117:1843-5.
20. American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993;92:295-6.
21. Greenwood BM. Polyarthritis in western Nigeria. II. Still's disease. Ann Rheum Dis 1969;28:617-23.
22. Schwartz MM, Simpson P, Kerr KL, Jarvis JN. Juvenile rheumatoid arthritis in African Americans. J Rheumatol 1997;24:1826-9.
23. Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 2007;56:1974-84.
24. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
25. Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain 2001;93:173-83.
26. Bieri D, Reeve RA, Champion GD, Addicoat L, Ziegler JB. The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties. Pain 1990;41:139-50.
27. Singh G, Athreya BH, Fries JF, Goldsmith DP. Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994;37:1761-9.
28. Chen CS, Roberton D, Hammerton ME. Juvenile arthritis-associated uveitis: visual outcomes and prognosis. Can J Ophthalmol 2004;39:614-20.
29. Saurenmann RK, Levin AV, Feldman BM, Rose JB, Laxer RM, Schneider R, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum 2007;56:647-57.
30. Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 2008;35:703-6.
31. Cassidy JT, Sullivan DB, Petty RE. Clinical patterns of chronic iridocyclitis in children with juvenile rheumatoid arthritis. Arthritis Rheum 1977;20 Suppl 2:224-7.
32. Sim KT, Venning HE, Barrett S, Gregson RM, Amoaku WM. Extended oligoarthritis and other risk factors for developing JIA-associated uveitis under ILAR classification and its implication for current screening guideline. Ocul Immunol Inflamm 2006;14:353-7.
33. Saurenmann RK, Levin AV, Feldman BM, Laxer RM, Schneider R, Silverman ED. Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum 2010;62:1824-8.
34. Ozdal PC, Vianna RN, Deschenes J. Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ocul Immunol Inflamm 2005;13:33-8.
35. Ayuso VK, Ten Cate HA, van der Does P, Rothova A, de Boer JH. Male gender and poor visual outcome in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 2010;149:987-93.
36. Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm 2011;19:139-44.
37. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. Acute anterior uveitis and HL-A 27. Lancet 1973;302:994-6.
38. Wladis EJ, Pappa C, Cavaliere LF. Anticyclic-citrullinated protein antibodies in the diagnosis of ophthalmic inflammatory disease. Ophthal Plast Reconstr Surg 2011;27:e1-2.
39. Itty S, Pulido JS, Bakri SJ, Baratz KH, Matteson EL, Hodge DO. Anti-cyclic citrullinated peptide, rheumatoid factor, and ocular symptoms typical of rheumatoid arthritis. Trans Am Ophthalmol Soc 2008;106:75-81; discussion 81-3.
40. Graham TB, Glass DN. Juvenile rheumatoid arthritis: ethnic differences in diagnostic types. J Rheumatol 1997;24:1677-9.
41. Haffejee IE, Raga J, Coovadia HM. Juvenile chronic arthritis in black and Indian South African children. S Afr Med J 1984; 65:510-4.
42. Angeles-Han ST, Griffin KW, Harrison MJ, Lehman TJ, Leong T, Robb RR, et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res 2011;63:1254-61.
43. Angeles-Han ST, Griffin KW, Lehman TJ, Rutledge JR, Lyman S, Nguyen JT, et al. The importance of visual function in the quality of life of children with uveitis. J AAPOS. 2010;14:163-8.
44. Maca SM, Amirian A, Prause C, Gruber K, Mejdoubi L, Barisani-Asenbauer T. Understanding the impact of uveitis on health-related quality of life in adolescents. Acta Ophthalmol 2013;91:e219-24.